Global 3D Cell Culture Market By Offering (Scaffold-based – Hydrogels, Inert matrices, Others, Scaffold-free – Low-adhesion plates, Micropatterned surfaces, Hanging drop, Rotating bioreactors, Magnetic levitation method (MLM), Magnetic 3D bioprinting) By Model (Tissue model, Spheroid Model, Organoid Model) By Applications (Drug Development, Cancer research, Stem cell research, Drug toxicity and screening, Tissue engineering, Others) By End Users (Research Centers, Biotechnology and pharmaceutical companies, Diagnostic centers, Others) By Region (North America (U.S., Canada, Mexico, Rest Of North America), Europe (France, The UK, Spain, Germany, Italy, Denmark, Finland, Iceland, Sweden, Norway, Belgium, The Netherlands, Luxembourg, Rest of Europe), Asia Pacific (China, Japan, India, New Zealand, Australia, South Korea, Southeast Asia, Indonesia, Thailand, Malaysia, Singapore, Rest of Southeast Asia, Rest of Asia Pacific, Middle East & Africa (Saudi Arabia, UAE, Egypt, Kuwait, South Africa, Rest of Middle East & Africa) Latin America (Brazil, Argentina, Rest of Latin America)) - Global Insights, Growth, Size, Comparative Analysis, Trends and Forecast, 2023 – 2031
Industry Trends
A 3D cell, more commonly known as a three-dimensional cell, happens to be a cell that has a complex shape and structure, instead of being a simple, flat, two-dimensional structure. In biology, cells primarily happen to be the basic building blocks of living organisms, and they can vary greatly in their shape and size. Few cells, like skin cells, are relatively flat and two-dimensional in shape, while on the other hand, those cells like nerve cells, are likely to be highly complex and three-dimensional. The three-dimensional shape of a cell is utterly key owing to its ability to perform its functions. For instance, a nerve cell has long, branching extensions that helps in transmitting signals over long distances, while a red blood cell has a unique biconcave shape that asks it to squeeze via those tiny blood vessels. In last couple of years, tremendous technological advancement has been seen which has allowed scientists to understand and manipulate 3D cells from a wider perspective. And this has led to new insights into the world of cell biology and potential applications in fields like tissue engineering and regenerative medicine. According to Absolute Markets Insights, the global 3D cell culture market is forecasted to touch $3.5 billion USD mark by the year 2026. The market’s growth is receiving impetus owing to multiple factors like spike in the need for organ transplantation, increasing focus on personalized medicine, surging prevalence of chronic diseases, and skyrocketing adoption of 3D cell culture techniques in drug discovery and toxicology testing. At present, the continent of North America is the largest region in the 3D cell culture market, followed by Europe and the Asia Pacific region. Within North America, the United States is the biggest market. On the other hand, China is likely to become the fastest-growing market in the region of Asia Pacific. The market is highly competitive, with numerous important players like Thermo Fisher Scientific Inc., Merck KGaA, Corning Incorporated and Lonza Group Ltd. The global 3D cell culture market is rampantly growing at a CAGR of 17.3% over the forecast period courtesy of several factors.
Type Outlook
Based on the type outlook, the global 3D cell culture market has been segmented into scaffold-based and scaffold-free. While the scaffold-based segment is bifurcated into hydrogels, inert matrices and others, the scaffold-free segment has been further categorised into low-adhesion plates, micropatterned surfaces, hanging drop, rotating bioreactors, magnetic levitation method (MLM) and magnetic 3D bioprinting. Scaffold-based 3D cell culture basically is a technique used to grow cells in a three-dimensional environment that mimics the extracellular matrix (ECM) of living tissues. This approach is inclusive of the use of a scaffold, which happens to be a three-dimensional structure that provides support for cells to grow and form tissue-like structures. These scaffolds can be created out of a variety of materials like natural polymers and inorganic materials.
Model Outlook
The model outlook segment of the global 3D cell culture market has been bifurcated into tissue model, spheroid model and organoid model. A tissue model basically is an experimental system that is brought in use to analyse the properties and behaviours of tissues, which are groups of specialized cells that work together for the purpose of performing specific functions in the human body. Tissue models can be produced in vitro, which means outside of the body, and are used in different types of applications, that include drug discovery, toxicology testing, and tissue engineering.
Region Outlook
Based on region, the continent of North America accounted for most of the money made by the global 3D cell culture market. The country of the United States and Canada has the best healthcare infrastructure on this planet. Huge investments is facilitating continuous medical research and this helps the market grow.
Competitive Landscape
The report provides both, qualitative and quantitative research of global 3D cell culture market, as well as provides comprehensive insights and development methods adopted by the key contenders. The report also offers extensive research on the key players in this market and details on the competitiveness of these players. Key business strategies such as mergers and acquisitions (M&A), affiliations, collaborations, and contracts adopted by these major market participants are also recognized and analysed in the report. For each company, the report studies their global presence, competitors, service offerings and specification amongst others.
Some of the players operating in the global 3D cell culture market are
- 3D Biomatrix
- Corning Incorporated
- Greiner Bio-One International GmbH
- InSphero
- Lonza
- Merck KGa
- PELOBIOTECH GmbH
- Promega Corporation
- PromoCell GmbH
- REPROCELL
- Tecan Trading AG
- Thermo Fisher Scientific Inc.
- VWR International LLC
- Other Market Participants
Global 3D Cell Culture Market:
By Type
- Scaffold-based
- Hydrogels
- Inert matrices
- Others
- Scaffold-free
- Low-adhesion plates
- Micropatterned surfaces
- Hanging drop
- Rotating bioreactors
- Magnetic levitation method (MLM)
- Magnetic 3D bioprinting
By Model
- Tissue model
- Spheroid Model
- Organoid Model
By Applications
- Drug Development
- Cancer research
- Stem cell research
- Drug toxicity and screening
- Tissue engineering
- Others
By End Users
- Research Centers
- Biotechnology and pharmaceutical companies
- Diagnostic centers
- Others
By Region
- North America (U.S., Canada, Mexico, Rest of North America)
- Europe (France, The UK, Spain, Germany, Italy, Nordic Countries (Denmark, Finland, Iceland, Sweden, Norway), Benelux Union (Belgium, The Netherlands, Luxembourg), Rest of Europe
- Asia Pacific (China, Japan, India, New Zealand, Australia, South Korea, Southeast Asia (Indonesia, Thailand, Malaysia, Singapore, Rest of Southeast Asia), Rest of Asia Pacific
- Middle East & Africa (Saudi Arabia, UAE, Egypt, Kuwait, South Africa, Rest of Middle East & Africa)
- Latin America (Brazil, Argentina, Rest of Latin America)
Table of Contents
1. Market Scope
1.1. Market
Segmentation
1.2. Years
Considered
1.2.1. Historic
Years: 2015 - 2021
1.2.2. Base
Year: 2022
1.2.3. Forecast
Years: 2023 - 2031
2. Key Target Audiences
3. Research Methodology
3.1. Primary
Research
3.1.1. Research
Questionnaire
3.1.2. Global
Percentage Breakdown
3.1.3. Primary
Interviews: Key Opinion Leaders (KOLs)
3.2. Secondary
Research
3.2.1. Paid
Databases
3.2.2. Secondary
Sources
3.3. Market
Size Estimates
3.3.1. Top-Down
Approach
3.3.2. Bottom-Up
Approach
3.4. Data
Triangulation Methodology
3.5. Research
Assumptions
4. Recommendations and Insights from AMI’s Perspective**
5. Holistic Overview of 3D Cell Culture Market
6. Market Synopsis: 3D
Cell Culture Market
7. 3D Cell Culture Market Analysis: Qualitative Perspective
7.1. Introduction
7.1.1. Product
Definition
7.1.2. Industry
Development
7.2. Market Dynamics
7.2.1. Drivers
7.2.2. Restraints
7.2.3. Opportunities
7.2.4. Challenges
7.3. Trends in 3D
Cell Culture Market
7.4. Market
Determinants Radar Chart
7.5. Macro-Economic
and Micro-Economic Indicators: 3D Cell Culture Market
7.6. Porter’s
Five Force Analysis
7.7. Impact of
Covid-19 on 3D Cell Culture Market
8. Global 3D Cell Culture Market Analysis and Forecasts, 2023 -
2031
8.1. Overview
8.1.1. Global 3D
Cell Culture Market Revenue (US$ Mn)
8.2. Global 3D
Cell Culture Market Revenue (US$ Mn) and Forecasts, By Type
8.2.1. Scaffold-based (Definition, Market Estimation and
Penetration, 2015 - 2022, Market Estimation (2015 - 2022), Market Forecast (2023
- 2031), Compound Annual Growth Rate (CAGR), Regional Bifurcation (North
America, Europe, Asia Pacific, Middle East and Africa, Latin America) and
Information on Hydrogels , Inert matrices, Others )
8.2.1.1. Hydrogels
8.2.1.2. Inert matrices
8.2.1.3. Others
8.2.2. Scaffold-free (Definition, Market Estimation and
Penetration, 2015 - 2022, Market Estimation (2015 - 2022), Market Forecast (2023
- 2031), Compound Annual Growth Rate (CAGR), Regional Bifurcation (North
America, Europe, Asia Pacific, Middle East and Africa, Latin America) and
Information on Low-adhesion plates, Micropatterned surfaces, Hanging drop,
Rotating bioreactors, Magnetic levitation method (MLM), Magnetic 3D
bioprinting)
8.2.2.1. Low-adhesion plates
8.2.2.2. Micropatterned surfaces
8.2.2.3. Hanging drop
8.2.2.4. Rotating bioreactors
8.2.2.5. Magnetic levitation method (MLM)
8.2.2.6. Magnetic 3D bioprinting
8.3. Key
Segment for Channeling Investments
8.3.1. By Type
9. Global 3D Cell Culture Market Analysis and Forecasts, 2023 -
2031
9.1. Overview
9.2. Global 3D
Cell Culture Market Revenue (US$ Mn) and Forecasts, By Model
9.2.1. Tissue
model
9.2.1.1. Definition
9.2.1.2. Market Estimation and Penetration, 2015 - 2022
9.2.1.3. Market Forecast, 2023 - 2031
9.2.1.4. Compound Annual Growth Rate (CAGR)
9.2.1.5. Regional Bifurcation
9.2.1.5.1. North America
9.2.1.5.1.1. Market
Estimation, 2015 - 2022
9.2.1.5.1.2. Market
Forecast, 2023 - 2031
9.2.1.5.2. Europe
9.2.1.5.2.1. Market
Estimation, 2015 - 2022
9.2.1.5.2.2. Market
Forecast, 2023 - 2031
9.2.1.5.3. Asia Pacific
9.2.1.5.3.1. Market
Estimation, 2015 - 2022
9.2.1.5.3.2. Market
Forecast, 2023 - 2031
9.2.1.5.4. Middle East and Africa
9.2.1.5.4.1. Market
Estimation, 2015 - 2022
9.2.1.5.4.2. Market
Forecast, 2023 - 2031
9.2.1.5.5. Latin America
9.2.1.5.5.1. Market
Estimation, 2015 - 2022
9.2.1.5.5.2. Market
Forecast, 2023 - 2031
9.2.2. Spheroid
Model
9.2.2.1. Definition
9.2.2.2. Market Estimation and Penetration, 2015 - 2022
9.2.2.3. Market Forecast, 2023 - 2031
9.2.2.4. Compound Annual Growth Rate (CAGR)
9.2.2.5. Regional Bifurcation
9.2.2.5.1. North America
9.2.2.5.1.1. Market
Estimation, 2015 - 2022
9.2.2.5.1.2. Market
Forecast, 2023 - 2031
9.2.2.5.2. Europe
9.2.2.5.2.1. Market
Estimation, 2015 - 2022
9.2.2.5.2.2. Market
Forecast, 2023 - 2031
9.2.2.5.3. Asia Pacific
9.2.2.5.3.1. Market
Estimation, 2015 - 2022
9.2.2.5.3.2. Market
Forecast, 2023 - 2031
9.2.2.5.4. Middle East and Africa
9.2.2.5.4.1. Market
Estimation, 2015 - 2022
9.2.2.5.4.2. Market
Forecast, 2023 - 2031
9.2.2.5.5. Latin America
9.2.2.5.5.1. Market
Estimation, 2015 - 2022
9.2.2.5.5.2. Market
Forecast, 2023 - 2031
9.2.3. Organoid
Model
9.2.3.1. Definition
9.2.3.2. Market Estimation and Penetration, 2015 - 2022
9.2.3.3. Market Forecast, 2023 - 2031
9.2.3.4. Compound Annual Growth Rate (CAGR)
9.2.3.5. Regional Bifurcation
9.2.3.5.1. North America
9.2.3.5.1.1. Market
Estimation, 2015 - 2022
9.2.3.5.1.2. Market
Forecast, 2023 - 2031
9.2.3.5.2. Europe
9.2.3.5.2.1. Market
Estimation, 2015 - 2022
9.2.3.5.2.2. Market
Forecast, 2023 - 2031
9.2.3.5.3. Asia Pacific
9.2.3.5.3.1. Market
Estimation, 2015 - 2022
9.2.3.5.3.2. Market
Forecast, 2023 - 2031
9.2.3.5.4. Middle East and Africa
9.2.3.5.4.1. Market
Estimation, 2015 - 2022
9.2.3.5.4.2. Market
Forecast, 2023 - 2031
9.2.3.5.5. Latin America
9.2.3.5.5.1. Market
Estimation, 2015 - 2022
9.2.3.5.5.2. Market
Forecast, 2023 - 2031
9.3. Key
Segment for Channeling Investments
9.3.1. By Model
10. Global 3D Cell Culture Market Analysis and Forecasts, 2023 -
2031
10.1. Overview
10.2. Global 3D
Cell Culture Market Revenue (US$ Mn) and Forecasts, By Applications
10.2.1. Drug
Development
10.2.1.1. Definition
10.2.1.2. Market Estimation and Penetration, 2015 - 2022
10.2.1.3. Market Forecast, 2023 - 2031
10.2.1.4. Compound Annual Growth Rate (CAGR)
10.2.1.5. Regional Bifurcation
10.2.1.5.1. North America
10.2.1.5.1.1. Market
Estimation, 2015 - 2022
10.2.1.5.1.2. Market
Forecast, 2023 - 2031
10.2.1.5.2. Europe
10.2.1.5.2.1. Market
Estimation, 2015 - 2022
10.2.1.5.2.2. Market
Forecast, 2023 - 2031
10.2.1.5.3. Asia Pacific
10.2.1.5.3.1. Market
Estimation, 2015 - 2022
10.2.1.5.3.2. Market
Forecast, 2023 - 2031
10.2.1.5.4. Middle East and Africa
10.2.1.5.4.1. Market
Estimation, 2015 - 2022
10.2.1.5.4.2. Market
Forecast, 2023 - 2031
10.2.1.5.5. Latin America
10.2.1.5.5.1. Market
Estimation, 2015 - 2022
10.2.1.5.5.2. Market
Forecast, 2023 - 2031
10.2.2. Cancer
research
10.2.2.1. Definition
10.2.2.2. Market Estimation and Penetration, 2015 - 2022
10.2.2.3. Market Forecast, 2023 - 2031
10.2.2.4. Compound Annual Growth Rate (CAGR)
10.2.2.5. Regional Bifurcation
10.2.2.5.1. North America
10.2.2.5.1.1. Market
Estimation, 2015 - 2022
10.2.2.5.1.2. Market
Forecast, 2023 - 2031
10.2.2.5.2. Europe
10.2.2.5.2.1. Market
Estimation, 2015 - 2022
10.2.2.5.2.2. Market
Forecast, 2023 - 2031
10.2.2.5.3. Asia Pacific
10.2.2.5.3.1. Market
Estimation, 2015 - 2022
10.2.2.5.3.2. Market
Forecast, 2023 - 2031
10.2.2.5.4. Middle East and Africa
10.2.2.5.4.1. Market
Estimation, 2015 - 2022
10.2.2.5.4.2. Market
Forecast, 2023 - 2031
10.2.2.5.5. Latin America
10.2.2.5.5.1. Market
Estimation, 2015 - 2022
10.2.2.5.5.2. Market
Forecast, 2023 - 2031
10.2.3. Stem
cell research
10.2.3.1. Definition
10.2.3.2. Market Estimation and Penetration, 2015 - 2022
10.2.3.3. Market Forecast, 2023 - 2031
10.2.3.4. Compound Annual Growth Rate (CAGR)
10.2.3.5. Regional Bifurcation
10.2.3.5.1. North America
10.2.3.5.1.1. Market
Estimation, 2015 - 2022
10.2.3.5.1.2. Market
Forecast, 2023 - 2031
10.2.3.5.2. Europe
10.2.3.5.2.1. Market
Estimation, 2015 - 2022
10.2.3.5.2.2. Market
Forecast, 2023 - 2031
10.2.3.5.3. Asia Pacific
10.2.3.5.3.1. Market
Estimation, 2015 - 2022
10.2.3.5.3.2. Market
Forecast, 2023 - 2031
10.2.3.5.4. Middle East and Africa
10.2.3.5.4.1. Market
Estimation, 2015 - 2022
10.2.3.5.4.2. Market
Forecast, 2023 - 2031
10.2.3.5.5. Latin America
10.2.3.5.5.1. Market
Estimation, 2015 - 2022
10.2.3.5.5.2. Market
Forecast, 2023 - 2031
10.2.4. Drug
toxicity and screening
10.2.4.1. Definition
10.2.4.2. Market Estimation and Penetration, 2015 - 2022
10.2.4.3. Market Forecast, 2023 - 2031
10.2.4.4. Compound Annual Growth Rate (CAGR)
10.2.4.5. Regional Bifurcation
10.2.4.5.1. North America
10.2.4.5.1.1. Market
Estimation, 2015 - 2022
10.2.4.5.1.2. Market
Forecast, 2023 - 2031
10.2.4.5.2. Europe
10.2.4.5.2.1. Market
Estimation, 2015 - 2022
10.2.4.5.2.2. Market
Forecast, 2023 - 2031
10.2.4.5.3. Asia Pacific
10.2.4.5.3.1. Market
Estimation, 2015 - 2022
10.2.4.5.3.2. Market
Forecast, 2023 - 2031
10.2.4.5.4. Middle East and Africa
10.2.4.5.4.1. Market
Estimation, 2015 - 2022
10.2.4.5.4.2. Market
Forecast, 2023 - 2031
10.2.4.5.5. Latin America
10.2.4.5.5.1. Market
Estimation, 2015 - 2022
10.2.4.5.5.2. Market
Forecast, 2023 - 2031
10.2.5. Tissue
engineering
10.2.5.1. Definition
10.2.5.2. Market Estimation and Penetration, 2015 - 2022
10.2.5.3. Market Forecast, 2023 - 2031
10.2.5.4. Compound Annual Growth Rate (CAGR)
10.2.5.5. Regional Bifurcation
10.2.5.5.1. North America
10.2.5.5.1.1. Market
Estimation, 2015 - 2022
10.2.5.5.1.2. Market
Forecast, 2023 - 2031
10.2.5.5.2. Europe
10.2.5.5.2.1. Market
Estimation, 2015 - 2022
10.2.5.5.2.2. Market
Forecast, 2023 - 2031
10.2.5.5.3. Asia Pacific
10.2.5.5.3.1. Market
Estimation, 2015 - 2022
10.2.5.5.3.2. Market
Forecast, 2023 - 2031
10.2.5.5.4. Middle East and Africa
10.2.5.5.4.1. Market
Estimation, 2015 - 2022
10.2.5.5.4.2. Market
Forecast, 2023 - 2031
10.2.5.5.5. Latin America
10.2.5.5.5.1. Market
Estimation, 2015 - 2022
10.2.5.5.5.2. Market
Forecast, 2023 - 2031
10.2.6. Others
10.2.6.1. Definition
10.2.6.2. Market Estimation and Penetration, 2015 - 2022
10.2.6.3. Market Forecast, 2023 - 2031
10.2.6.4. Compound Annual Growth Rate (CAGR)
10.2.6.5. Regional Bifurcation
10.2.6.5.1. North America
10.2.6.5.1.1. Market
Estimation, 2015 - 2022
10.2.6.5.1.2. Market
Forecast, 2023 - 2031
10.2.6.5.2. Europe
10.2.6.5.2.1. Market
Estimation, 2015 - 2022
10.2.6.5.2.2. Market
Forecast, 2023 - 2031
10.2.6.5.3. Asia Pacific
10.2.6.5.3.1. Market
Estimation, 2015 - 2022
10.2.6.5.3.2. Market
Forecast, 2023 - 2031
10.2.6.5.4. Middle East and Africa
10.2.6.5.4.1. Market
Estimation, 2015 - 2022
10.2.6.5.4.2. Market
Forecast, 2023 - 2031
10.2.6.5.5. Latin America
10.2.6.5.5.1. Market
Estimation, 2015 - 2022
10.2.6.5.5.2. Market
Forecast, 2023 - 2031
10.3. Key
Segment for Channeling Investments
10.3.1. By
Applications
11. Global 3D Cell Culture Market Analysis and Forecasts, 2023 -
2031
11.1. Overview
11.2. Global 3D
Cell Culture Market Revenue (US$ Mn) and Forecasts, By End Users
11.2.1. Research
Centers
11.2.1.1. Definition
11.2.1.2. Market Estimation and Penetration, 2015 - 2022
11.2.1.3. Market Forecast, 2023 - 2031
11.2.1.4. Compound Annual Growth Rate (CAGR)
11.2.1.5. Regional Bifurcation
11.2.1.5.1. North America
11.2.1.5.1.1. Market
Estimation, 2015 - 2022
11.2.1.5.1.2. Market
Forecast, 2023 - 2031
11.2.1.5.2. Europe
11.2.1.5.2.1. Market
Estimation, 2015 - 2022
11.2.1.5.2.2. Market
Forecast, 2023 - 2031
11.2.1.5.3. Asia Pacific
11.2.1.5.3.1. Market
Estimation, 2015 - 2022
11.2.1.5.3.2. Market
Forecast, 2023 - 2031
11.2.1.5.4. Middle East and Africa
11.2.1.5.4.1. Market
Estimation, 2015 - 2022
11.2.1.5.4.2. Market
Forecast, 2023 - 2031
11.2.1.5.5. Latin America
11.2.1.5.5.1. Market
Estimation, 2015 - 2022
11.2.1.5.5.2. Market
Forecast, 2023 - 2031
11.2.2. Biotechnology
and pharmaceutical companies
11.2.2.1. Definition
11.2.2.2. Market Estimation and Penetration, 2015 - 2022
11.2.2.3. Market Forecast, 2023 - 2031
11.2.2.4. Compound Annual Growth Rate (CAGR)
11.2.2.5. Regional Bifurcation
11.2.2.5.1. North America
11.2.2.5.1.1. Market
Estimation, 2015 - 2022
11.2.2.5.1.2. Market
Forecast, 2023 - 2031
11.2.2.5.2. Europe
11.2.2.5.2.1. Market
Estimation, 2015 - 2022
11.2.2.5.2.2. Market
Forecast, 2023 - 2031
11.2.2.5.3. Asia Pacific
11.2.2.5.3.1. Market
Estimation, 2015 - 2022
11.2.2.5.3.2. Market
Forecast, 2023 - 2031
11.2.2.5.4. Middle East and Africa
11.2.2.5.4.1. Market
Estimation, 2015 - 2022
11.2.2.5.4.2. Market
Forecast, 2023 - 2031
11.2.2.5.5. Latin America
11.2.2.5.5.1. Market
Estimation, 2015 - 2022
11.2.2.5.5.2. Market
Forecast, 2023 - 2031
11.2.3. Diagnostic
center
11.2.3.1. Definition
11.2.3.2. Market Estimation and Penetration, 2015 - 2022
11.2.3.3. Market Forecast, 2023 - 2031
11.2.3.4. Compound Annual Growth Rate (CAGR)
11.2.3.5. Regional Bifurcation
11.2.3.5.1. North America
11.2.3.5.1.1. Market
Estimation, 2015 - 2022
11.2.3.5.1.2. Market
Forecast, 2023 - 2031
11.2.3.5.2. Europe
11.2.3.5.2.1. Market
Estimation, 2015 - 2022
11.2.3.5.2.2. Market
Forecast, 2023 - 2031
11.2.3.5.3. Asia Pacific
11.2.3.5.3.1. Market
Estimation, 2015 - 2022
11.2.3.5.3.2. Market
Forecast, 2023 - 2031
11.2.3.5.4. Middle East and Africa
11.2.3.5.4.1. Market
Estimation, 2015 - 2022
11.2.3.5.4.2. Market
Forecast, 2023 - 2031
11.2.3.5.5. Latin America
11.2.3.5.5.1. Market
Estimation, 2015 - 2022
11.2.3.5.5.2. Market
Forecast, 2023 - 2031
11.2.4. Others
11.2.4.1. Definition
11.2.4.2. Market Estimation and Penetration, 2015 - 2022
11.2.4.3. Market Forecast, 2023 - 2031
11.2.4.4. Compound Annual Growth Rate (CAGR)
11.2.4.5. Regional Bifurcation
11.2.4.5.1. North America
11.2.4.5.1.1. Market
Estimation, 2015 - 2022
11.2.4.5.1.2. Market
Forecast, 2023 - 2031
11.2.4.5.2. Europe
11.2.4.5.2.1. Market
Estimation, 2015 - 2022
11.2.4.5.2.2. Market
Forecast, 2023 - 2031
11.2.4.5.3. Asia Pacific
11.2.4.5.3.1. Market
Estimation, 2015 - 2022
11.2.4.5.3.2. Market
Forecast, 2023 - 2031
11.2.4.5.4. Middle East and Africa
11.2.4.5.4.1. Market
Estimation, 2015 - 2022
11.2.4.5.4.2. Market
Forecast, 2023 - 2031
11.2.4.5.5. Latin America
11.2.4.5.5.1. Market
Estimation, 2015 - 2022
11.2.4.5.5.2. Market
Forecast, 2023 - 2031
11.3. Key
Segment for Channeling Investments
11.3.1. By End
Users
12. North America 3D Cell Culture Market Analysis and Forecasts, 2023
- 2031
12.1. Overview
12.1.1. North
America 3D Cell Culture Market Revenue (US$ Mn)
12.2. North
America 3D Cell Culture Market Revenue (US$ Mn) and Forecasts, By Type
12.2.1. Scaffold-based
12.2.1.1. Hydrogels
12.2.1.2. Inert matrices
12.2.1.3. Others
12.2.2. Scaffold-free
12.2.2.1. Low-adhesion plates
12.2.2.2. Micropatterned surfaces
12.2.2.3. Hanging drop
12.2.2.4. Rotating bioreactors
12.2.2.5. Magnetic levitation method (MLM)
12.2.2.6. Magnetic 3D bioprinting
12.3. North America
3D Cell Culture Market Revenue (US$ Mn) and Forecasts, By Model
12.3.1. Tissue
model
12.3.2. Spheroid
Model
12.3.3. Organoid
Model
12.4. North
America 3D Cell Culture Market Revenue (US$ Mn) and Forecasts, By Applications
12.4.1. Drug
Development
12.4.2. Cancer
research
12.4.3. Stem
cell research
12.4.4. Drug
toxicity and screening
12.4.5. Tissue
engineering
12.4.6. Others
12.5. North
America 3D Cell Culture Market Revenue (US$ Mn) and Forecasts, By End Users
12.5.1. Research
Centers
12.5.2. Biotechnology
and pharmaceutical companies
12.5.3. Diagnostic
center
12.5.4. Others
12.6. North
America 3D Cell Culture Market Revenue (US$ Mn) and Forecasts, By Country
12.6.1. U.S
12.6.1.1. U.S 3D Cell Culture Market Revenue (US$ Mn) and Forecasts, By
Type
12.6.1.1.1. Scaffold-based
12.6.1.1.1.1. Hydrogels
12.6.1.1.1.2. Inert
matrices
12.6.1.1.1.3. Others
12.6.1.1.2. Scaffold-free
12.6.1.1.2.1. Low-adhesion
plates
12.6.1.1.2.2. Micropatterned
surfaces
12.6.1.1.2.3. Hanging
drop
12.6.1.1.2.4. Rotating
bioreactors
12.6.1.1.2.5. Magnetic
levitation method (MLM)
12.6.1.1.2.6. Magnetic
3D bioprinting
12.6.1.2. U.S 3D Cell Culture Market Revenue (US$ Mn) and Forecasts, By
Model
12.6.1.2.1. Tissue model
12.6.1.2.2. Spheroid Model
12.6.1.2.3. Organoid Model
12.6.1.3. U.S 3D Cell Culture Market Revenue (US$ Mn) and Forecasts, By
Applications
12.6.1.3.1. Drug Development
12.6.1.3.2. Cancer research
12.6.1.3.3. Stem cell research
12.6.1.3.4. Drug toxicity and screening
12.6.1.3.5. Tissue engineering
12.6.1.3.6. Others
12.6.1.4. U.S 3D Cell Culture Market Revenue (US$ Mn) and Forecasts, By
End Users
12.6.1.4.1. Research Centers
12.6.1.4.2. Biotechnology and pharmaceutical companies
12.6.1.4.3. Diagnostic center
12.6.1.4.4. Others
12.6.2. Canada
12.6.2.1. Canada 3D Cell Culture Market Revenue (US$ Mn) and Forecasts,
By Type
12.6.2.1.1. Scaffold-based
12.6.2.1.1.1. Hydrogels
12.6.2.1.1.2. Inert
matrices
12.6.2.1.1.3. Others
12.6.2.1.2. Scaffold-free
12.6.2.1.2.1. Low-adhesion
plates
12.6.2.1.2.2. Micropatterned
surfaces
12.6.2.1.2.3. Hanging
drop
12.6.2.1.2.4. Rotating
bioreactors
12.6.2.1.2.5. Magnetic
levitation method (MLM)
12.6.2.1.2.6. Magnetic
3D bioprinting
12.6.2.2. Canada 3D Cell Culture Market Revenue (US$ Mn) and Forecasts,
By Model
12.6.2.2.1. Tissue model
12.6.2.2.2. Spheroid Model
12.6.2.2.3. Organoid Model
12.6.2.3. Canada 3D Cell Culture Market Revenue (US$ Mn) and Forecasts,
By Applications
12.6.2.3.1. Drug Development
12.6.2.3.2. Cancer research
12.6.2.3.3. Stem cell research
12.6.2.3.4. Drug toxicity and screening
12.6.2.3.5. Tissue engineering
12.6.2.3.6. Others
12.6.2.4. Canada 3D Cell Culture Market Revenue (US$ Mn) and Forecasts,
By End Users
12.6.2.4.1. Research Centers
12.6.2.4.2. Biotechnology and pharmaceutical companies
12.6.2.4.3. Diagnostic center
12.6.2.4.4. Others
12.6.3. Mexico
12.6.3.1. Mexico 3D Cell Culture Market Revenue (US$ Mn) and Forecasts,
By Type
12.6.3.1.1. Scaffold-based
12.6.3.1.1.1. Hydrogels
12.6.3.1.1.2. Inert
matrices
12.6.3.1.1.3. Others
12.6.3.1.2. Scaffold-free
12.6.3.1.2.1. Low-adhesion
plates
12.6.3.1.2.2. Micropatterned
surfaces
12.6.3.1.2.3. Hanging
drop
12.6.3.1.2.4. Rotating
bioreactors
12.6.3.1.2.5. Magnetic
levitation method (MLM)
12.6.3.1.2.6. Magnetic
3D bioprinting
12.6.3.2. Mexico 3D Cell Culture Market Revenue (US$ Mn) and Forecasts,
By Model
12.6.3.2.1. Tissue model
12.6.3.2.2. Spheroid Model
12.6.3.2.3. Organoid Model
12.6.3.3. Mexico 3D Cell Culture Market Revenue (US$ Mn) and Forecasts,
By Applications
12.6.3.3.1. Drug Development
12.6.3.3.2. Cancer research
12.6.3.3.3. Stem cell research
12.6.3.3.4. Drug toxicity and screening
12.6.3.3.5. Tissue engineering
12.6.3.3.6. Others
12.6.3.4. Mexico 3D Cell Culture Market Revenue (US$ Mn) and Forecasts,
By End Users
12.6.3.4.1. Research Centers
12.6.3.4.2. Biotechnology and pharmaceutical companies
12.6.3.4.3. Diagnostic center
12.6.3.4.4. Others
12.6.4. Rest of
North America
12.6.4.1. Rest of North America 3D Cell Culture Market Revenue (US$ Mn)
and Forecasts, By Type
12.6.4.1.1. Scaffold-based
12.6.4.1.1.1. Hydrogels
12.6.4.1.1.2. Inert
matrices
12.6.4.1.1.3. Others
12.6.4.1.2. Scaffold-free
12.6.4.1.2.1. Low-adhesion
plates
12.6.4.1.2.2. Micropatterned
surfaces
12.6.4.1.2.3. Hanging
drop
12.6.4.1.2.4. Rotating
bioreactors
12.6.4.1.2.5. Magnetic
levitation method (MLM)
12.6.4.1.2.6. Magnetic
3D bioprinting
12.6.4.2. Rest of North America 3D Cell Culture Market Revenue (US$ Mn)
and Forecasts, By Model
12.6.4.2.1. Tissue model
12.6.4.2.2. Spheroid Model
12.6.4.2.3. Organoid Model
12.6.4.3. Rest of North America 3D Cell Culture Market Revenue (US$ Mn)
and Forecasts, By Applications
12.6.4.3.1. Drug Development
12.6.4.3.2. Cancer research
12.6.4.3.3. Stem cell research
12.6.4.3.4. Drug toxicity and screening
12.6.4.3.5. Tissue engineering
12.6.4.3.6. Others
12.6.4.4. Rest of North America 3D Cell Culture Market Revenue (US$ Mn)
and Forecasts, By End Users
12.6.4.4.1. Research Centers
12.6.4.4.2. Biotechnology and pharmaceutical companies
12.6.4.4.3. Diagnostic center
12.6.4.4.4. Others
12.7. Key
Segment for Channeling Investments
12.7.1. By
Country
12.7.2. By Type
12.7.3. By
Model
12.7.4. By
Applications
12.7.5. By End
Users
13. Europe 3D Cell Culture Market Analysis and Forecasts, 2023 -
2031
13.1. Overview
13.1.1. Europe 3D
Cell Culture Market Revenue (US$ Mn)
13.2. Europe 3D
Cell Culture Market Revenue (US$ Mn) and Forecasts, By Type
13.2.1. Scaffold-based
13.2.1.1. Hydrogels
13.2.1.2. Inert matrices
13.2.1.3. Others
13.2.2. Scaffold-free
13.2.2.1. Low-adhesion plates
13.2.2.2. Micropatterned surfaces
13.2.2.3. Hanging drop
13.2.2.4. Rotating bioreactors
13.2.2.5. Magnetic levitation method (MLM)
13.2.2.6. Magnetic 3D bioprinting
13.3. Europe 3D
Cell Culture Market Revenue (US$ Mn) and Forecasts, By Model
13.3.1. Tissue
model
13.3.2. Spheroid
Model
13.3.3. Organoid
Model
13.4. Europe 3D
Cell Culture Market Revenue (US$ Mn) and Forecasts, By Applications
13.4.1. Drug
Development
13.4.2. Cancer
research
13.4.3. Stem
cell research
13.4.4. Drug toxicity
and screening
13.4.5. Tissue
engineering
13.4.6. Others
13.5. Europe 3D
Cell Culture Market Revenue (US$ Mn) and Forecasts, By End Users
13.5.1. Research
Centers
13.5.2. Biotechnology
and pharmaceutical companies
13.5.3. Diagnostic
center
13.5.4. Others
13.6. Europe 3D
Cell Culture Market Revenue (US$ Mn) and Forecasts, By Country
13.6.1. France
13.6.1.1. France 3D Cell Culture Market Revenue (US$ Mn) and Forecasts,
By Type
13.6.1.1.1. Scaffold-based
13.6.1.1.1.1. Hydrogels
13.6.1.1.1.2. Inert
matrices
13.6.1.1.1.3. Others
13.6.1.1.2. Scaffold-free
13.6.1.1.2.1. Low-adhesion
plates
13.6.1.1.2.2. Micropatterned
surfaces
13.6.1.1.2.3. Hanging
drop
13.6.1.1.2.4. Rotating
bioreactors
13.6.1.1.2.5. Magnetic
levitation method (MLM)
13.6.1.1.2.6. Magnetic
3D bioprinting
13.6.1.2. France 3D Cell Culture Market Revenue (US$ Mn) and Forecasts,
By Model
13.6.1.2.1. Tissue model
13.6.1.2.2. Spheroid Model
13.6.1.2.3. Organoid Model
13.6.1.3. France 3D Cell Culture Market Revenue (US$ Mn) and Forecasts,
By Applications
13.6.1.3.1. Drug Development
13.6.1.3.2. Cancer research
13.6.1.3.3. Stem cell research
13.6.1.3.4. Drug toxicity and screening
13.6.1.3.5. Tissue engineering
13.6.1.3.6. Others
13.6.1.4. France 3D Cell Culture Market Revenue (US$ Mn) and Forecasts,
By End Users
13.6.1.4.1. Research Centers
13.6.1.4.2. Biotechnology and pharmaceutical companies
13.6.1.4.3. Diagnostic center
13.6.1.4.4. Others
13.6.2. The UK
13.6.2.1. The UK 3D Cell Culture Market Revenue (US$ Mn) and Forecasts,
By Type
13.6.2.1.1. Scaffold-based
13.6.2.1.1.1. Hydrogels
13.6.2.1.1.2. Inert
matrices
13.6.2.1.1.3. Others
13.6.2.1.2. Scaffold-free
13.6.2.1.2.1. Low-adhesion
plates
13.6.2.1.2.2. Micropatterned
surfaces
13.6.2.1.2.3. Hanging
drop
13.6.2.1.2.4. Rotating
bioreactors
13.6.2.1.2.5. Magnetic
levitation method (MLM)
13.6.2.1.2.6. Magnetic
3D bioprinting
13.6.2.2. The UK 3D Cell Culture Market Revenue (US$ Mn) and Forecasts,
By Model
13.6.2.2.1. Tissue model
13.6.2.2.2. Spheroid Model
13.6.2.2.3. Organoid Model
13.6.2.3. The UK 3D Cell Culture Market Revenue (US$ Mn) and Forecasts,
By Applications
13.6.2.3.1. Drug Development
13.6.2.3.2. Cancer research
13.6.2.3.3. Stem cell research
13.6.2.3.4. Drug toxicity and screening
13.6.2.3.5. Tissue engineering
13.6.2.3.6. Others
13.6.2.4. The UK 3D Cell Culture Market Revenue (US$ Mn) and Forecasts,
By End Users
13.6.2.4.1. Research Centers
13.6.2.4.2. Biotechnology and pharmaceutical companies
13.6.2.4.3. Diagnostic center
13.6.2.4.4. Others
13.6.3. Spain
13.6.3.1. Spain 3D Cell Culture Market Revenue (US$ Mn) and Forecasts,
By Type
13.6.3.1.1. Scaffold-based
13.6.3.1.1.1. Hydrogels
13.6.3.1.1.2. Inert
matrices
13.6.3.1.1.3. Others
13.6.3.1.2. Scaffold-free
13.6.3.1.2.1. Low-adhesion
plates
13.6.3.1.2.2. Micropatterned
surfaces
13.6.3.1.2.3. Hanging
drop
13.6.3.1.2.4. Rotating
bioreactors
13.6.3.1.2.5. Magnetic
levitation method (MLM)
13.6.3.1.2.6. Magnetic
3D bioprinting
13.6.3.2. Spain 3D Cell Culture Market Revenue (US$ Mn) and Forecasts,
By Model
13.6.3.2.1. Tissue model
13.6.3.2.2. Spheroid Model
13.6.3.2.3. Organoid Model
13.6.3.3. Spain 3D Cell Culture Market Revenue (US$ Mn) and Forecasts,
By Applications
13.6.3.3.1. Drug Development
13.6.3.3.2. Cancer research
13.6.3.3.3. Stem cell research
13.6.3.3.4. Drug toxicity and screening
13.6.3.3.5. Tissue engineering
13.6.3.3.6. Others
13.6.3.4. Spain 3D Cell Culture Market Revenue (US$ Mn) and Forecasts,
By End Users
13.6.3.4.1. Research Centers
13.6.3.4.2. Biotechnology and pharmaceutical companies
13.6.3.4.3. Diagnostic center
13.6.3.4.4. Others
13.6.4. Germany
13.6.4.1. Germany 3D Cell Culture Market Revenue (US$ Mn) and Forecasts,
By Type
13.6.4.1.1. Scaffold-based
13.6.4.1.1.1. Hydrogels
13.6.4.1.1.2. Inert
matrices
13.6.4.1.1.3. Others
13.6.4.1.2. Scaffold-free
13.6.4.1.2.1. Low-adhesion
plates
13.6.4.1.2.2. Micropatterned
surfaces
13.6.4.1.2.3. Hanging
drop
13.6.4.1.2.4. Rotating
bioreactors
13.6.4.1.2.5. Magnetic
levitation method (MLM)
13.6.4.1.2.6. Magnetic
3D bioprinting
13.6.4.2. Germany 3D Cell Culture Market Revenue (US$ Mn) and Forecasts,
By Model
13.6.4.2.1. Tissue model
13.6.4.2.2. Spheroid Model
13.6.4.2.3. Organoid Model
13.6.4.3. Germany 3D Cell Culture Market Revenue (US$ Mn) and Forecasts,
By Applications
13.6.4.3.1. Drug Development
13.6.4.3.2. Cancer research
13.6.4.3.3. Stem cell research
13.6.4.3.4. Drug toxicity and screening
13.6.4.3.5. Tissue engineering
13.6.4.3.6. Others
13.6.4.4. Germany 3D Cell Culture Market Revenue (US$ Mn) and Forecasts,
By End Users
13.6.4.4.1. Research Centers
13.6.4.4.2. Biotechnology and pharmaceutical companies
13.6.4.4.3. Diagnostic center
13.6.4.4.4. Others
13.6.5. Italy
13.6.5.1. Italy 3D Cell Culture Market Revenue (US$ Mn) and Forecasts,
By Type
13.6.5.1.1. Scaffold-based
13.6.5.1.1.1. Hydrogels
13.6.5.1.1.2. Inert
matrices
13.6.5.1.1.3. Others
13.6.5.1.2. Scaffold-free
13.6.5.1.2.1. Low-adhesion
plates
13.6.5.1.2.2. Micropatterned
surfaces
13.6.5.1.2.3. Hanging
drop
13.6.5.1.2.4. Rotating
bioreactors
13.6.5.1.2.5. Magnetic
levitation method (MLM)
13.6.5.1.2.6. Magnetic
3D bioprinting
13.6.5.2. Italy 3D Cell Culture Market Revenue (US$ Mn) and Forecasts,
By Model
13.6.5.2.1. Tissue model
13.6.5.2.2. Spheroid Model
13.6.5.2.3. Organoid Model
13.6.5.3. Italy 3D Cell Culture Market Revenue (US$ Mn) and Forecasts,
By Applications
13.6.5.3.1. Drug Development
13.6.5.3.2. Cancer research
13.6.5.3.3. Stem cell research
13.6.5.3.4. Drug toxicity and screening
13.6.5.3.5. Tissue engineering
13.6.5.3.6. Others
13.6.5.4. Italy 3D Cell Culture Market Revenue (US$ Mn) and Forecasts,
By End Users
13.6.5.4.1. Research Centers
13.6.5.4.2. Biotechnology and pharmaceutical companies
13.6.5.4.3. Diagnostic center
13.6.5.4.4. Others
13.6.6. Nordic
Countries
13.6.6.1. Nordic Countries 3D Cell Culture Market Revenue (US$ Mn) and
Forecasts, By Type
13.6.6.1.1. Scaffold-based
13.6.6.1.1.1. Hydrogels
13.6.6.1.1.2. Inert
matrices
13.6.6.1.1.3. Others
13.6.6.1.2. Scaffold-free
13.6.6.1.2.1. Low-adhesion
plates
13.6.6.1.2.2. Micropatterned
surfaces
13.6.6.1.2.3. Hanging
drop
13.6.6.1.2.4. Rotating
bioreactors
13.6.6.1.2.5. Magnetic
levitation method (MLM)
13.6.6.1.2.6. Magnetic
3D bioprinting
13.6.6.2. Nordic Countries 3D Cell Culture Market Revenue (US$ Mn) and
Forecasts, By Model
13.6.6.2.1. Tissue model
13.6.6.2.2. Spheroid Model
13.6.6.2.3. Organoid Model
13.6.6.3. Nordic Countries 3D Cell Culture Market Revenue (US$ Mn) and
Forecasts, By Applications
13.6.6.3.1. Drug Development
13.6.6.3.2. Cancer research
13.6.6.3.3. Stem cell research
13.6.6.3.4. Drug toxicity and screening
13.6.6.3.5. Tissue engineering
13.6.6.3.6. Others
13.6.6.4. Nordic Countries 3D Cell Culture Market Revenue (US$ Mn) and
Forecasts, By End Users
13.6.6.4.1. Research Centers
13.6.6.4.2. Biotechnology and pharmaceutical companies
13.6.6.4.3. Diagnostic center
13.6.6.4.4. Others
13.6.6.5. Nordic Countries 3D Cell Culture Market Revenue (US$ Mn) and
Forecasts, By Country
13.6.6.5.1. Denmark
13.6.6.5.2. Finland
13.6.6.5.3. Iceland
13.6.6.5.4. Sweden
13.6.6.5.5. Norway
13.6.7. Benelux
Union
13.6.7.1. Benelux Union 3D Cell Culture Market Revenue (US$ Mn) and
Forecasts, By Type
13.6.7.1.1. Scaffold-based
13.6.7.1.1.1. Hydrogels
13.6.7.1.1.2. Inert
matrices
13.6.7.1.1.3. Others
13.6.7.1.2. Scaffold-free
13.6.7.1.2.1. Low-adhesion
plates
13.6.7.1.2.2. Micropatterned
surfaces
13.6.7.1.2.3. Hanging
drop
13.6.7.1.2.4. Rotating
bioreactors
13.6.7.1.2.5. Magnetic
levitation method (MLM)
13.6.7.1.2.6. Magnetic
3D bioprinting
13.6.7.2. Benelux Union 3D Cell Culture Market Revenue (US$ Mn) and
Forecasts, By Model
13.6.7.2.1. Tissue model
13.6.7.2.2. Spheroid Model
13.6.7.2.3. Organoid Model
13.6.7.3. Benelux Union 3D Cell Culture Market Revenue (US$ Mn) and
Forecasts, By Applications
13.6.7.3.1. Drug Development
13.6.7.3.2. Cancer research
13.6.7.3.3. Stem cell research
13.6.7.3.4. Drug toxicity and screening
13.6.7.3.5. Tissue engineering
13.6.7.3.6. Others
13.6.7.4. Benelux Union 3D Cell Culture Market Revenue (US$ Mn) and
Forecasts, By End Users
13.6.7.4.1. Research Centers
13.6.7.4.2. Biotechnology and pharmaceutical companies
13.6.7.4.3. Diagnostic center
13.6.7.4.4. Others
13.6.7.5. Benelux Union 3D Cell Culture Market Revenue (US$ Mn) and
Forecasts, By Country
13.6.7.5.1. Belgium
13.6.7.5.2. The Netherlands
13.6.7.5.3. Luxembourg
13.6.8. Rest of
Europe
13.6.8.1. Rest of Europe 3D Cell Culture Market Revenue (US$ Mn) and
Forecasts, By Type
13.6.8.1.1. Scaffold-based
13.6.8.1.1.1. Hydrogels
13.6.8.1.1.2. Inert
matrices
13.6.8.1.1.3. Others
13.6.8.1.2. Scaffold-free
13.6.8.1.2.1. Low-adhesion
plates
13.6.8.1.2.2. Micropatterned
surfaces
13.6.8.1.2.3. Hanging
drop
13.6.8.1.2.4. Rotating
bioreactors
13.6.8.1.2.5. Magnetic
levitation method (MLM)
13.6.8.1.2.6. Magnetic
3D bioprinting
13.6.8.2. Rest of Europe 3D Cell Culture Market Revenue (US$ Mn) and
Forecasts, By Model
13.6.8.2.1. Tissue model
13.6.8.2.2. Spheroid Model
13.6.8.2.3. Organoid Model
13.6.8.3. Rest of Europe 3D Cell Culture Market Revenue (US$ Mn) and
Forecasts, By Applications
13.6.8.3.1. Drug Development
13.6.8.3.2. Cancer research
13.6.8.3.3. Stem cell research
13.6.8.3.4. Drug toxicity and screening
13.6.8.3.5. Tissue engineering
13.6.8.3.6. Others
13.6.8.4. Rest of Europe 3D Cell Culture Market Revenue (US$ Mn) and
Forecasts, By End Users
13.6.8.4.1. Research Centers
13.6.8.4.2. Biotechnology and pharmaceutical companies
13.6.8.4.3. Diagnostic center
13.6.8.4.4. Others
13.7. Key
Segment for Channeling Investments
13.7.1. By
Country
13.7.2. By Type
13.7.3. By
Model
13.7.4. By
Applications
13.7.5. By End
Users
14. Asia Pacific 3D Cell Culture Market Analysis and Forecasts, 2023
- 2031
14.1. Overview
14.1.1. Asia
Pacific 3D Cell Culture Market Revenue (US$ Mn)
14.2. Asia
Pacific 3D Cell Culture Market Revenue (US$ Mn) and Forecasts, By Type
14.2.1. Scaffold-based
14.2.1.1. Hydrogels
14.2.1.2. Inert matrices
14.2.1.3. Others
14.2.2. Scaffold-free
14.2.2.1. Low-adhesion plates
14.2.2.2. Micropatterned surfaces
14.2.2.3. Hanging drop
14.2.2.4. Rotating bioreactors
14.2.2.5. Magnetic levitation method (MLM)
14.2.2.6. Magnetic 3D bioprinting
14.3. Asia
Pacific 3D Cell Culture Market Revenue (US$ Mn) and Forecasts, By Model
14.3.1. Tissue
model
14.3.2. Spheroid
Model
14.3.3. Organoid
Model
14.4. Asia
Pacific 3D Cell Culture Market Revenue (US$ Mn) and Forecasts, By Applications
14.4.1. Drug
Development
14.4.2. Cancer
research
14.4.3. Stem
cell research
14.4.4. Drug
toxicity and screening
14.4.5. Tissue
engineering
14.4.6. Others
14.5. Asia
Pacific 3D Cell Culture Market Revenue (US$ Mn) and Forecasts, By End Users
14.5.1. Research
Centers
14.5.2. Biotechnology
and pharmaceutical companies
14.5.3. Diagnostic
center
14.5.4. Others
14.6. Asia
Pacific 3D Cell Culture Market Revenue (US$ Mn) and Forecasts, By Country
14.6.1. China
14.6.1.1. China 3D Cell Culture Market Revenue (US$ Mn) and Forecasts,
By Type
14.6.1.1.1. Scaffold-based
14.6.1.1.1.1. Hydrogels
14.6.1.1.1.2. Inert
matrices
14.6.1.1.1.3. Others
14.6.1.1.2. Scaffold-free
14.6.1.1.2.1. Low-adhesion
plates
14.6.1.1.2.2. Micropatterned
surfaces
14.6.1.1.2.3. Hanging
drop
14.6.1.1.2.4. Rotating
bioreactors
14.6.1.1.2.5. Magnetic
levitation method (MLM)
14.6.1.1.2.6. Magnetic
3D bioprinting
14.6.1.2. China 3D Cell Culture Market Revenue (US$ Mn) and Forecasts,
By Model
14.6.1.2.1. Tissue model
14.6.1.2.2. Spheroid Model
14.6.1.2.3. Organoid Model
14.6.1.3. China 3D Cell Culture Market Revenue (US$ Mn) and Forecasts,
By Applications
14.6.1.3.1. Drug Development
14.6.1.3.2. Cancer research
14.6.1.3.3. Stem cell research
14.6.1.3.4. Drug toxicity and screening
14.6.1.3.5. Tissue engineering
14.6.1.3.6. Others
14.6.1.4. China 3D Cell Culture Market Revenue (US$ Mn) and Forecasts,
By End Users
14.6.1.4.1. Research Centers
14.6.1.4.2. Biotechnology and pharmaceutical companies
14.6.1.4.3. Diagnostic center
14.6.1.4.4. Others
14.6.2. Japan
14.6.2.1. Japan 3D Cell Culture Market Revenue (US$ Mn) and Forecasts,
By Type
14.6.2.1.1. Scaffold-based
14.6.2.1.1.1. Hydrogels
14.6.2.1.1.2. Inert
matrices
14.6.2.1.1.3. Others
14.6.2.1.2. Scaffold-free
14.6.2.1.2.1. Low-adhesion
plates
14.6.2.1.2.2. Micropatterned
surfaces
14.6.2.1.2.3. Hanging
drop
14.6.2.1.2.4. Rotating
bioreactors
14.6.2.1.2.5. Magnetic
levitation method (MLM)
14.6.2.1.2.6. Magnetic
3D bioprinting
14.6.2.2. Japan 3D Cell Culture Market Revenue (US$ Mn) and Forecasts,
By Model
14.6.2.2.1. Tissue model
14.6.2.2.2. Spheroid Model
14.6.2.2.3. Organoid Model
14.6.2.3. Japan 3D Cell Culture Market Revenue (US$ Mn) and Forecasts,
By Applications
14.6.2.3.1. Drug Development
14.6.2.3.2. Cancer research
14.6.2.3.3. Stem cell research
14.6.2.3.4. Drug toxicity and screening
14.6.2.3.5. Tissue engineering
14.6.2.3.6. Others
14.6.2.4. Japan 3D Cell Culture Market Revenue (US$ Mn) and Forecasts,
By End Users
14.6.2.4.1. Research Centers
14.6.2.4.2. Biotechnology and pharmaceutical companies
14.6.2.4.3. Diagnostic center
14.6.2.4.4. Others
14.6.3. India
14.6.3.1. India 3D Cell Culture Market Revenue (US$ Mn) and Forecasts,
By Type
14.6.3.1.1. Scaffold-based
14.6.3.1.1.1. Hydrogels
14.6.3.1.1.2. Inert
matrices
14.6.3.1.1.3. Others
14.6.3.1.2. Scaffold-free
14.6.3.1.2.1. Low-adhesion
plates
14.6.3.1.2.2. Micropatterned
surfaces
14.6.3.1.2.3. Hanging
drop
14.6.3.1.2.4. Rotating
bioreactors
14.6.3.1.2.5. Magnetic
levitation method (MLM)
14.6.3.1.2.6. Magnetic
3D bioprinting
14.6.3.2. India 3D Cell Culture Market Revenue (US$ Mn) and Forecasts,
By Model
14.6.3.2.1. Tissue model
14.6.3.2.2. Spheroid Model
14.6.3.2.3. Organoid Model
14.6.3.3. India 3D Cell Culture Market Revenue (US$ Mn) and Forecasts,
By Applications
14.6.3.3.1. Drug Development
14.6.3.3.2. Cancer research
14.6.3.3.3. Stem cell research
14.6.3.3.4. Drug toxicity and screening
14.6.3.3.5. Tissue engineering
14.6.3.3.6. Others
14.6.3.4. India 3D Cell Culture Market Revenue (US$ Mn) and Forecasts,
By End Users
14.6.3.4.1. Research Centers
14.6.3.4.2. Biotechnology and pharmaceutical companies
14.6.3.4.3. Diagnostic center
14.6.3.4.4. Others
14.6.4. New
Zealand
14.6.4.1. New Zealand 3D Cell Culture Market Revenue (US$ Mn) and
Forecasts, By Type
14.6.4.1.1. Scaffold-based
14.6.4.1.1.1. Hydrogels
14.6.4.1.1.2. Inert
matrices
14.6.4.1.1.3. Others
14.6.4.1.2. Scaffold-free
14.6.4.1.2.1. Low-adhesion
plates
14.6.4.1.2.2. Micropatterned
surfaces
14.6.4.1.2.3. Hanging
drop
14.6.4.1.2.4. Rotating
bioreactors
14.6.4.1.2.5. Magnetic
levitation method (MLM)
14.6.4.1.2.6. Magnetic
3D bioprinting
14.6.4.2. New Zealand 3D Cell Culture Market Revenue (US$ Mn) and
Forecasts, By Model
14.6.4.2.1. Tissue model
14.6.4.2.2. Spheroid Model
14.6.4.2.3. Organoid Model
14.6.4.3. New Zealand 3D Cell Culture Market Revenue (US$ Mn) and
Forecasts, By Applications
14.6.4.3.1. Drug Development
14.6.4.3.2. Cancer research
14.6.4.3.3. Stem cell research
14.6.4.3.4. Drug toxicity and screening
14.6.4.3.5. Tissue engineering
14.6.4.3.6. Others
14.6.4.4. New Zealand 3D Cell Culture Market Revenue (US$ Mn) and
Forecasts, By End Users
14.6.4.4.1. Research Centers
14.6.4.4.2. Biotechnology and pharmaceutical companies
14.6.4.4.3. Diagnostic center
14.6.4.4.4. Others
14.6.5. Australia
14.6.5.1. Australia 3D Cell Culture Market Revenue (US$ Mn) and
Forecasts, By Type
14.6.5.1.1. Scaffold-based
14.6.5.1.1.1. Hydrogels
14.6.5.1.1.2. Inert
matrices
14.6.5.1.1.3. Others
14.6.5.1.2. Scaffold-free
14.6.5.1.2.1. Low-adhesion
plates
14.6.5.1.2.2. Micropatterned
surfaces
14.6.5.1.2.3. Hanging
drop
14.6.5.1.2.4. Rotating
bioreactors
14.6.5.1.2.5. Magnetic
levitation method (MLM)
14.6.5.1.2.6. Magnetic
3D bioprinting
14.6.5.2. Australia 3D Cell Culture Market Revenue (US$ Mn) and
Forecasts, By Model
14.6.5.2.1. Tissue model
14.6.5.2.2. Spheroid Model
14.6.5.2.3. Organoid Model
14.6.5.3. Australia 3D Cell Culture Market Revenue (US$ Mn) and
Forecasts, By Applications
14.6.5.3.1. Drug Development
14.6.5.3.2. Cancer research
14.6.5.3.3. Stem cell research
14.6.5.3.4. Drug toxicity and screening
14.6.5.3.5. Tissue engineering
14.6.5.3.6. Others
14.6.5.4. Australia 3D Cell Culture Market Revenue (US$ Mn) and
Forecasts, By End Users
14.6.5.4.1. Research Centers
14.6.5.4.2. Biotechnology and pharmaceutical companies
14.6.5.4.3. Diagnostic center
14.6.5.4.4. Others
14.6.6. South Korea
14.6.6.1. South Korea 3D Cell Culture Market Revenue (US$ Mn) and
Forecasts, By Type
14.6.6.1.1. Scaffold-based
14.6.6.1.1.1. Hydrogels
14.6.6.1.1.2. Inert
matrices
14.6.6.1.1.3. Others
14.6.6.1.2. Scaffold-free
14.6.6.1.2.1. Low-adhesion
plates
14.6.6.1.2.2. Micropatterned
surfaces
14.6.6.1.2.3. Hanging
drop
14.6.6.1.2.4. Rotating
bioreactors
14.6.6.1.2.5. Magnetic
levitation method (MLM)
14.6.6.1.2.6. Magnetic
3D bioprinting
14.6.6.2. South Korea 3D Cell Culture Market Revenue (US$ Mn) and
Forecasts, By Model
14.6.6.2.1. Tissue model
14.6.6.2.2. Spheroid Model
14.6.6.2.3. Organoid Model
14.6.6.3. South Korea 3D Cell Culture Market Revenue (US$ Mn) and
Forecasts, By Applications
14.6.6.3.1. Drug Development
14.6.6.3.2. Cancer research
14.6.6.3.3. Stem cell research
14.6.6.3.4. Drug toxicity and screening
14.6.6.3.5. Tissue engineering
14.6.6.3.6. Others
14.6.6.4. South Korea 3D Cell Culture Market Revenue (US$ Mn) and
Forecasts, By End Users
14.6.6.4.1. Research Centers
14.6.6.4.2. Biotechnology and pharmaceutical companies
14.6.6.4.3. Diagnostic center
14.6.6.4.4. Others
14.6.7. Southeast
Asia
14.6.7.1. Southeast Asia 3D Cell Culture Market Revenue (US$ Mn) and
Forecasts, By Type
14.6.7.1.1. Scaffold-based
14.6.7.1.1.1. Hydrogels
14.6.7.1.1.2. Inert
matrices
14.6.7.1.1.3. Others
14.6.7.1.2. Scaffold-free
14.6.7.1.2.1. Low-adhesion
plates
14.6.7.1.2.2. Micropatterned
surfaces
14.6.7.1.2.3. Hanging
drop
14.6.7.1.2.4. Rotating
bioreactors
14.6.7.1.2.5. Magnetic
levitation method (MLM)
14.6.7.1.2.6. Magnetic
3D bioprinting
14.6.7.2. Southeast Asia 3D Cell Culture Market Revenue (US$ Mn) and
Forecasts, By Model
14.6.7.2.1. Tissue model
14.6.7.2.2. Spheroid Model
14.6.7.2.3. Organoid Model
14.6.7.3. Southeast Asia 3D Cell Culture Market Revenue (US$ Mn) and
Forecasts, By Applications
14.6.7.3.1. Drug Development
14.6.7.3.2. Cancer research
14.6.7.3.3. Stem cell research
14.6.7.3.4. Drug toxicity and screening
14.6.7.3.5. Tissue engineering
14.6.7.3.6. Others
14.6.7.4. Southeast Asia 3D Cell Culture Market Revenue (US$ Mn) and
Forecasts, By End Users
14.6.7.4.1. Research Centers
14.6.7.4.2. Biotechnology and pharmaceutical companies
14.6.7.4.3. Diagnostic center
14.6.7.4.4. Others
14.6.7.5. Southeast Asia 3D Cell Culture Market Revenue (US$ Mn) and
Forecasts, By Country
14.6.7.5.1. Indonesia
14.6.7.5.2. Thailand
14.6.7.5.3. Malaysia
14.6.7.5.4. Singapore
14.6.7.5.5. Rest of Southeast Asia
14.6.8. Rest of
Asia Pacific
14.6.8.1. Rest of Asia Pacific 3D Cell Culture Market Revenue (US$ Mn)
and Forecasts, By Type
14.6.8.1.1. Scaffold-based
14.6.8.1.1.1. Hydrogels
14.6.8.1.1.2. Inert
matrices
14.6.8.1.1.3. Others
14.6.8.1.2. Scaffold-free
14.6.8.1.2.1. Low-adhesion
plates
14.6.8.1.2.2. Micropatterned
surfaces
14.6.8.1.2.3. Hanging
drop
14.6.8.1.2.4. Rotating
bioreactors
14.6.8.1.2.5. Magnetic
levitation method (MLM)
14.6.8.1.2.6. Magnetic
3D bioprinting
14.6.8.2. Rest of Asia Pacific 3D Cell Culture Market Revenue (US$ Mn)
and Forecasts, By Model
14.6.8.2.1. Tissue model
14.6.8.2.2. Spheroid Model
14.6.8.2.3. Organoid Model
14.6.8.3. Rest of Asia Pacific 3D Cell Culture Market Revenue (US$ Mn)
and Forecasts, By Applications
14.6.8.3.1. Drug Development
14.6.8.3.2. Cancer research
14.6.8.3.3. Stem cell research
14.6.8.3.4. Drug toxicity and screening
14.6.8.3.5. Tissue engineering
14.6.8.3.6. Others
14.6.8.4. Rest of Asia Pacific 3D Cell Culture Market Revenue (US$ Mn)
and Forecasts, By End Users
14.6.8.4.1. Research Centers
14.6.8.4.2. Biotechnology and pharmaceutical companies
14.6.8.4.3. Diagnostic center
14.6.8.4.4. Others
14.7. Key Segment
for Channeling Investments
14.7.1. By
Country
14.7.2. By Type
14.7.3. By
Model
14.7.4. By
Applications
14.7.5. By End
Users
15. Middle East and Africa 3D Cell Culture Market Analysis and
Forecasts, 2023 - 2031
15.1. Overview
15.1.1. Middle
East and Africa 3D Cell Culture Market Revenue (US$ Mn)
15.2. Middle
East and Africa 3D Cell Culture Market Revenue (US$ Mn) and Forecasts, By Type
15.2.1. Scaffold-based
15.2.1.1. Hydrogels
15.2.1.2. Inert matrices
15.2.1.3. Others
15.2.2. Scaffold-free
15.2.2.1. Low-adhesion plates
15.2.2.2. Micropatterned surfaces
15.2.2.3. Hanging drop
15.2.2.4. Rotating bioreactors
15.2.2.5. Magnetic levitation method (MLM)
15.2.2.6. Magnetic 3D bioprinting
15.3. Middle
East and Africa 3D Cell Culture Market Revenue (US$ Mn) and Forecasts, By Model
15.3.1. Tissue
model
15.3.2. Spheroid
Model
15.3.3. Organoid
Model
15.4. Middle
East and Africa 3D Cell Culture Market Revenue (US$ Mn) and Forecasts, By
Applications
15.4.1. Drug
Development
15.4.2. Cancer
research
15.4.3. Stem
cell research
15.4.4. Drug
toxicity and screening
15.4.5. Tissue
engineering
15.4.6. Others
15.5. Middle
East and Africa 3D Cell Culture Market Revenue (US$ Mn) and Forecasts, By End
Users
15.5.1. Research
Centers
15.5.2. Biotechnology
and pharmaceutical companies
15.5.3. Diagnostic
center
15.5.4. Others
15.6. Middle
East and Africa 3D Cell Culture Market Revenue (US$ Mn) and Forecasts, By
Country
15.6.1. Saudi
Arabia
15.6.1.1. Saudi Arabia 3D Cell Culture Market Revenue (US$ Mn) and
Forecasts, By Type
15.6.1.1.1. Scaffold-based
15.6.1.1.1.1. Hydrogels
15.6.1.1.1.2. Inert
matrices
15.6.1.1.1.3. Others
15.6.1.1.2. Scaffold-free
15.6.1.1.2.1. Low-adhesion
plates
15.6.1.1.2.2. Micropatterned
surfaces
15.6.1.1.2.3. Hanging
drop
15.6.1.1.2.4. Rotating
bioreactors
15.6.1.1.2.5. Magnetic
levitation method (MLM)
15.6.1.1.2.6. Magnetic
3D bioprinting
15.6.1.2. Saudi Arabia 3D Cell Culture Market Revenue (US$ Mn) and
Forecasts, By Model
15.6.1.2.1. Tissue model
15.6.1.2.2. Spheroid Model
15.6.1.2.3. Organoid Model
15.6.1.3. Saudi Arabia 3D Cell Culture Market Revenue (US$ Mn) and
Forecasts, By Applications
15.6.1.3.1. Drug Development
15.6.1.3.2. Cancer research
15.6.1.3.3. Stem cell research
15.6.1.3.4. Drug toxicity and screening
15.6.1.3.5. Tissue engineering
15.6.1.3.6. Others
15.6.1.4. Saudi Arabia 3D Cell Culture Market Revenue (US$ Mn) and
Forecasts, By End Users
15.6.1.4.1. Research Centers
15.6.1.4.2. Biotechnology and pharmaceutical companies
15.6.1.4.3. Diagnostic center
15.6.1.4.4. Others
15.6.2. UAE
15.6.2.1. UAE 3D Cell Culture Market Revenue (US$ Mn) and Forecasts, By
Type
15.6.2.1.1. Scaffold-based
15.6.2.1.1.1. Hydrogels
15.6.2.1.1.2. Inert
matrices
15.6.2.1.1.3. Others
15.6.2.1.2. Scaffold-free
15.6.2.1.2.1. Low-adhesion
plates
15.6.2.1.2.2. Micropatterned
surfaces
15.6.2.1.2.3. Hanging
drop
15.6.2.1.2.4. Rotating
bioreactors
15.6.2.1.2.5. Magnetic
levitation method (MLM)
15.6.2.1.2.6. Magnetic
3D bioprinting
15.6.2.2. UAE 3D Cell Culture Market Revenue (US$ Mn) and Forecasts, By
Model
15.6.2.2.1. Tissue model
15.6.2.2.2. Spheroid Model
15.6.2.2.3. Organoid Model
15.6.2.3. UAE 3D Cell Culture Market Revenue (US$ Mn) and Forecasts, By
Applications
15.6.2.3.1. Drug Development
15.6.2.3.2. Cancer research
15.6.2.3.3. Stem cell research
15.6.2.3.4. Drug toxicity and screening
15.6.2.3.5. Tissue engineering
15.6.2.3.6. Others
15.6.2.4. UAE 3D Cell Culture Market Revenue (US$ Mn) and Forecasts, By
End Users
15.6.2.4.1. Research Centers
15.6.2.4.2. Biotechnology and pharmaceutical companies
15.6.2.4.3. Diagnostic center
15.6.2.4.4. Others
15.6.3. Egypt
15.6.3.1. Egypt 3D Cell Culture Market Revenue (US$ Mn) and Forecasts,
By Type
15.6.3.1.1. Scaffold-based
15.6.3.1.1.1. Hydrogels
15.6.3.1.1.2. Inert
matrices
15.6.3.1.1.3. Others
15.6.3.1.2. Scaffold-free
15.6.3.1.2.1. Low-adhesion
plates
15.6.3.1.2.2. Micropatterned
surfaces
15.6.3.1.2.3. Hanging
drop
15.6.3.1.2.4. Rotating
bioreactors
15.6.3.1.2.5. Magnetic
levitation method (MLM)
15.6.3.1.2.6. Magnetic
3D bioprinting
15.6.3.2. Egypt 3D Cell Culture Market Revenue (US$ Mn) and Forecasts,
By Model
15.6.3.2.1. Tissue model
15.6.3.2.2. Spheroid Model
15.6.3.2.3. Organoid Model
15.6.3.3. Egypt 3D Cell Culture Market Revenue (US$ Mn) and Forecasts,
By Applications
15.6.3.3.1. Drug Development
15.6.3.3.2. Cancer research
15.6.3.3.3. Stem cell research
15.6.3.3.4. Drug toxicity and screening
15.6.3.3.5. Tissue engineering
15.6.3.3.6. Others
15.6.3.4. Egypt 3D Cell Culture Market Revenue (US$ Mn) and Forecasts,
By End Users
15.6.3.4.1. Research Centers
15.6.3.4.2. Biotechnology and pharmaceutical companies
15.6.3.4.3. Diagnostic center
15.6.3.4.4. Others
15.6.4. Kuwait
15.6.4.1. Kuwait 3D Cell Culture Market Revenue (US$ Mn) and Forecasts,
By Type
15.6.4.1.1. Scaffold-based
15.6.4.1.1.1. Hydrogels
15.6.4.1.1.2. Inert
matrices
15.6.4.1.1.3. Others
15.6.4.1.2. Scaffold-free
15.6.4.1.2.1. Low-adhesion
plates
15.6.4.1.2.2. Micropatterned
surfaces
15.6.4.1.2.3. Hanging
drop
15.6.4.1.2.4. Rotating
bioreactors
15.6.4.1.2.5. Magnetic
levitation method (MLM)
15.6.4.1.2.6. Magnetic
3D bioprinting
15.6.4.2. Kuwait 3D Cell Culture Market Revenue (US$ Mn) and Forecasts,
By Model
15.6.4.2.1. Tissue model
15.6.4.2.2. Spheroid Model
15.6.4.2.3. Organoid Model
15.6.4.3. Kuwait 3D Cell Culture Market Revenue (US$ Mn) and Forecasts,
By Applications
15.6.4.3.1. Drug Development
15.6.4.3.2. Cancer research
15.6.4.3.3. Stem cell research
15.6.4.3.4. Drug toxicity and screening
15.6.4.3.5. Tissue engineering
15.6.4.3.6. Others
15.6.4.4. Kuwait 3D Cell Culture Market Revenue (US$ Mn) and Forecasts,
By End Users
15.6.4.4.1. Research Centers
15.6.4.4.2. Biotechnology and pharmaceutical companies
15.6.4.4.3. Diagnostic center
15.6.4.4.4. Others
15.6.5. South
Africa
15.6.5.1. South Africa 3D Cell Culture Market Revenue (US$ Mn) and
Forecasts, By Type
15.6.5.1.1. Scaffold-based
15.6.5.1.1.1. Hydrogels
15.6.5.1.1.2. Inert
matrices
15.6.5.1.1.3. Others
15.6.5.1.2. Scaffold-free
15.6.5.1.2.1. Low-adhesion
plates
15.6.5.1.2.2. Micropatterned
surfaces
15.6.5.1.2.3. Hanging
drop
15.6.5.1.2.4. Rotating
bioreactors
15.6.5.1.2.5. Magnetic
levitation method (MLM)
15.6.5.1.2.6. Magnetic
3D bioprinting
15.6.5.2. South Africa 3D Cell Culture Market Revenue (US$ Mn) and
Forecasts, By Model
15.6.5.2.1. Tissue model
15.6.5.2.2. Spheroid Model
15.6.5.2.3. Organoid Model
15.6.5.3. South Africa 3D Cell Culture Market Revenue (US$ Mn) and
Forecasts, By Applications
15.6.5.3.1. Drug Development
15.6.5.3.2. Cancer research
15.6.5.3.3. Stem cell research
15.6.5.3.4. Drug toxicity and screening
15.6.5.3.5. Tissue engineering
15.6.5.3.6. Others
15.6.5.4. South Africa 3D Cell Culture Market Revenue (US$ Mn) and
Forecasts, By End Users
15.6.5.4.1. Research Centers
15.6.5.4.2. Biotechnology and pharmaceutical companies
15.6.5.4.3. Diagnostic center
15.6.5.4.4. Others
15.6.6. Rest of
Middle East & Africa
15.6.6.1. Rest of Middle East & Africa 3D Cell Culture Market
Revenue (US$ Mn) and Forecasts, By Type
15.6.6.1.1. Scaffold-based
15.6.6.1.1.1. Hydrogels
15.6.6.1.1.2. Inert
matrices
15.6.6.1.1.3. Others
15.6.6.1.2. Scaffold-free
15.6.6.1.2.1. Low-adhesion
plates
15.6.6.1.2.2. Micropatterned
surfaces
15.6.6.1.2.3. Hanging
drop
15.6.6.1.2.4. Rotating
bioreactors
15.6.6.1.2.5. Magnetic
levitation method (MLM)
15.6.6.1.2.6. Magnetic
3D bioprinting
15.6.6.2. Rest of Middle East & Africa 3D Cell Culture Market
Revenue (US$ Mn) and Forecasts, By Model
15.6.6.2.1. Tissue model
15.6.6.2.2. Spheroid Model
15.6.6.2.3. Organoid Model
15.6.6.3. Rest of Middle East & Africa 3D Cell Culture Market
Revenue (US$ Mn) and Forecasts, By Applications
15.6.6.3.1. Drug Development
15.6.6.3.2. Cancer research
15.6.6.3.3. Stem cell research
15.6.6.3.4. Drug toxicity and screening
15.6.6.3.5. Tissue engineering
15.6.6.3.6. Others
15.6.6.4. Rest of Middle East & Africa 3D Cell Culture Market
Revenue (US$ Mn) and Forecasts, By End Users
15.6.6.4.1. Research Centers
15.6.6.4.2. Biotechnology and pharmaceutical companies
15.6.6.4.3. Diagnostic center
15.6.6.4.4. Others
15.7. Key
Segment for Channeling Investments
15.7.1. By
Country
15.7.2. By Type
15.7.3. By
Model
15.7.4. By
Applications
15.7.5. By End
Users
16. Latin America 3D Cell Culture Market Analysis and Forecasts, 2023
- 2031
16.1. Overview
16.1.1. Latin
America 3D Cell Culture Market Revenue (US$ Mn)
16.2. Latin
America 3D Cell Culture Market Revenue (US$ Mn) and Forecasts, By Type
16.2.1. Scaffold-based
16.2.1.1. Hydrogels
16.2.1.2. Inert matrices
16.2.1.3. Others
16.2.2. Scaffold-free
16.2.2.1. Low-adhesion plates
16.2.2.2. Micropatterned surfaces
16.2.2.3. Hanging drop
16.2.2.4. Rotating bioreactors
16.2.2.5. Magnetic levitation method (MLM)
16.2.2.6. Magnetic 3D bioprinting
16.3. Latin
America 3D Cell Culture Market Revenue (US$ Mn) and Forecasts, By Model
16.3.1. Tissue
model
16.3.2. Spheroid
Model
16.3.3. Organoid
Model
16.4. Latin
America 3D Cell Culture Market Revenue (US$ Mn) and Forecasts, By Applications
16.4.1. Drug
Development
16.4.2. Cancer
research
16.4.3. Stem
cell research
16.4.4. Drug
toxicity and screening
16.4.5. Tissue
engineering
16.4.6. Others
16.5. Latin
America 3D Cell Culture Market Revenue (US$ Mn) and Forecasts, By End Users
16.5.1. Research
Centers
16.5.2. Biotechnology
and pharmaceutical companies
16.5.3. Diagnostic
center
16.5.4. Others
16.6. Latin
America 3D Cell Culture Market Revenue (US$ Mn) and Forecasts, By Country
16.6.1. Brazil
16.6.1.1. Brazil 3D Cell Culture Market Revenue (US$ Mn) and Forecasts,
By Type
16.6.1.1.1. Scaffold-based
16.6.1.1.1.1. Hydrogels
16.6.1.1.1.2. Inert
matrices
16.6.1.1.1.3. Others
16.6.1.1.2. Scaffold-free
16.6.1.1.2.1. Low-adhesion
plates
16.6.1.1.2.2. Micropatterned
surfaces
16.6.1.1.2.3. Hanging
drop
16.6.1.1.2.4. Rotating
bioreactors
16.6.1.1.2.5. Magnetic
levitation method (MLM)
16.6.1.1.2.6. Magnetic
3D bioprinting
16.6.1.2. Brazil 3D Cell Culture Market Revenue (US$ Mn) and Forecasts,
By Model
16.6.1.2.1. Tissue model
16.6.1.2.2. Spheroid Model
16.6.1.2.3. Organoid Model
16.6.1.3. Brazil 3D Cell Culture Market Revenue (US$ Mn) and Forecasts,
By Applications
16.6.1.3.1. Drug Development
16.6.1.3.2. Cancer research
16.6.1.3.3. Stem cell research
16.6.1.3.4. Drug toxicity and screening
16.6.1.3.5. Tissue engineering
16.6.1.3.6. Others
16.6.1.4. Brazil 3D Cell Culture Market Revenue (US$ Mn) and Forecasts,
By End Users
16.6.1.4.1. Research Centers
16.6.1.4.2. Biotechnology and pharmaceutical companies
16.6.1.4.3. Diagnostic center
16.6.1.4.4. Others
16.6.2. Argentina
16.6.2.1. Argentina 3D Cell Culture Market Revenue (US$ Mn) and
Forecasts, By Type
16.6.2.1.1. Scaffold-based
16.6.2.1.1.1. Hydrogels
16.6.2.1.1.2. Inert
matrices
16.6.2.1.1.3. Others
16.6.2.1.2. Scaffold-free
16.6.2.1.2.1. Low-adhesion
plates
16.6.2.1.2.2. Micropatterned
surfaces
16.6.2.1.2.3. Hanging
drop
16.6.2.1.2.4. Rotating
bioreactors
16.6.2.1.2.5. Magnetic
levitation method (MLM)
16.6.2.1.2.6. Magnetic
3D bioprinting
16.6.2.2. Argentina 3D Cell Culture Market Revenue (US$ Mn) and
Forecasts, By Model
16.6.2.2.1. Tissue model
16.6.2.2.2. Spheroid Model
16.6.2.2.3. Organoid Model
16.6.2.3. Argentina 3D Cell Culture Market Revenue (US$ Mn) and
Forecasts, By Applications
16.6.2.3.1. Drug Development
16.6.2.3.2. Cancer research
16.6.2.3.3. Stem cell research
16.6.2.3.4. Drug toxicity and screening
16.6.2.3.5. Tissue engineering
16.6.2.3.6. Others
16.6.2.4. Argentina 3D Cell Culture Market Revenue (US$ Mn) and
Forecasts, By End Users
16.6.2.4.1. Research Centers
16.6.2.4.2. Biotechnology and pharmaceutical companies
16.6.2.4.3. Diagnostic center
16.6.2.4.4. Others
16.6.3. Rest of
Latin America
16.6.3.1. Rest of Latin America 3D Cell Culture Market Revenue (US$ Mn)
and Forecasts, By Type
16.6.3.1.1. Scaffold-based
16.6.3.1.1.1. Hydrogels
16.6.3.1.1.2. Inert
matrices
16.6.3.1.1.3. Others
16.6.3.1.2. Scaffold-free
16.6.3.1.2.1. Low-adhesion
plates
16.6.3.1.2.2. Micropatterned
surfaces
16.6.3.1.2.3. Hanging
drop
16.6.3.1.2.4. Rotating
bioreactors
16.6.3.1.2.5. Magnetic
levitation method (MLM)
16.6.3.1.2.6. Magnetic
3D bioprinting
16.6.3.2. Rest of Latin America 3D Cell Culture Market Revenue (US$ Mn)
and Forecasts, By Model
16.6.3.2.1. Tissue model
16.6.3.2.2. Spheroid Model
16.6.3.2.3. Organoid Model
16.6.3.3. Rest of Latin America 3D Cell Culture Market Revenue (US$ Mn)
and Forecasts, By Applications
16.6.3.3.1. Drug Development
16.6.3.3.2. Cancer research
16.6.3.3.3. Stem cell research
16.6.3.3.4. Drug toxicity and screening
16.6.3.3.5. Tissue engineering
16.6.3.3.6. Others
16.6.3.4. Rest of Latin America 3D Cell Culture Market Revenue (US$ Mn)
and Forecasts, By End Users
16.6.3.4.1. Research Centers
16.6.3.4.2. Biotechnology and pharmaceutical companies
16.6.3.4.3. Diagnostic center
16.6.3.4.4. Others
16.7. Key
Segment for Channeling Investments
16.7.1. By
Country
16.7.2. By Type
16.7.3. By
Model
16.7.4. By
Applications
16.7.5. By End
Users
17. Competitive Benchmarking
17.1. Brand
Benchmarking
17.2. Market
Share Analysis, 2022
17.3. Global
Presence and Growth Strategies
17.3.1. Mergers
and Acquisitions
17.3.2. Product
Launches
17.3.3. Investments
Trends
17.3.4. R&D
Initiatives
18. Player Profiles
18.1. 3D
Biomatrix
18.1.1. Company
Details
18.1.2. Company
Overview
18.1.3. Product
Offerings
18.1.4. Key
Developments
18.1.5. Financial
Analysis
18.1.6. SWOT
Analysis
18.1.7. Business
Strategies
18.2. Corning
Incorporated
18.2.1. Company
Details
18.2.2. Company
Overview
18.2.3. Product
Offerings
18.2.4. Key
Developments
18.2.5. Financial
Analysis
18.2.6. SWOT
Analysis
18.2.7. Business
Strategies
18.3. Greiner
Bio-One International GmbH
18.3.1. Company
Details
18.3.2. Company
Overview
18.3.3. Product
Offerings
18.3.4. Key
Developments
18.3.5. Financial
Analysis
18.3.6. SWOT Analysis
18.3.7. Business
Strategies
18.4. InSphero
18.4.1. Company
Details
18.4.2. Company
Overview
18.4.3. Product
Offerings
18.4.4. Key
Developments
18.4.5. Financial
Analysis
18.4.6. SWOT
Analysis
18.4.7. Business
Strategies
18.5. Lonza
18.5.1. Company
Details
18.5.2. Company
Overview
18.5.3. Product
Offerings
18.5.4. Key
Developments
18.5.5. Financial
Analysis
18.5.6. SWOT
Analysis
18.5.7. Business
Strategies
18.6. Merck
KGaA
18.6.1. Company
Details
18.6.2. Company
Overview
18.6.3. Product
Offerings
18.6.4. Key
Developments
18.6.5. Financial
Analysis
18.6.6. SWOT
Analysis
18.6.7. Business
Strategies
18.7. PELOBIOTECH
GmbH
18.7.1. Company
Details
18.7.2. Company
Overview
18.7.3. Product
Offerings
18.7.4. Key Developments
18.7.5. Financial
Analysis
18.7.6. SWOT
Analysis
18.7.7. Business
Strategies
18.8. Promega
Corporation
18.8.1. Company
Details
18.8.2. Company
Overview
18.8.3. Product
Offerings
18.8.4. Key
Developments
18.8.5. Financial
Analysis
18.8.6. SWOT
Analysis
18.8.7. Business
Strategies
18.9. PromoCell
GmbH
18.9.1. Company
Details
18.9.2. Company
Overview
18.9.3. Product
Offerings
18.9.4. Key
Developments
18.9.5. Financial
Analysis
18.9.6. SWOT
Analysis
18.9.7. Business
Strategies
18.10. REPROCELL
Inc.
18.10.1. Company
Details
18.10.2. Company
Overview
18.10.3. Product
Offerings
18.10.4. Key
Developments
18.10.5. Financial
Analysis
18.10.6. SWOT
Analysis
18.10.7. Business
Strategies
18.11. Tecan
Trading AG
18.11.1. Company
Details
18.11.2. Company
Overview
18.11.3. Product
Offerings
18.11.4. Key
Developments
18.11.5. Financial
Analysis
18.11.6. SWOT
Analysis
18.11.7. Business
Strategies
18.12. Thermo
Fisher Scientific Inc
18.12.1. Company
Details
18.12.2. Company
Overview
18.12.3. Product
Offerings
18.12.4. Key
Developments
18.12.5. Financial
Analysis
18.12.6. SWOT
Analysis
18.12.7. Business
Strategies
18.13. VWR
International, LLC
18.13.1. Company
Details
18.13.2. Company
Overview
18.13.3. Product
Offerings
18.13.4. Key
Developments
18.13.5. Financial
Analysis
18.13.6. SWOT
Analysis
18.13.7. Business Strategies
18.14. Other
Market Participants
19. Key Findings
Note: This ToC is tentative and can be changed
according to the research study conducted during the course of
report completion.
**Exclusive for Multi-User and Enterprise User.
At Absolute Markets Insights, we are engaged in building both global as well as country specific reports. As a result, the approach taken for deriving the estimation and forecast for a specific country is a bit unique and different in comparison to the global research studies. In this case, we not only study the concerned market factors & trends prevailing in a particular country (from secondary research) but we also tend to calculate the actual market size & forecast from the revenue generated from the market participants involved in manufacturing or distributing the any concerned product. These companies can also be service providers. For analyzing any country specifically, we do consider the growth factors prevailing under the states/cities/county for the same. For instance, if we are analyzing an industry specific to United States, we primarily need to study about the states present under the same(where the product/service has the highest growth). Similar analysis will be followed by other countries. Our scope of the report changes with different markets.
Our research study is mainly implement through a mix of both secondary and primary research. Various sources such as industry magazines, trade journals, and government websites and trade associations are reviewed for gathering precise data. Primary interviews are conducted to validate the market size derived from secondary research. Industry experts, major manufacturers and distributors are contacted for further validation purpose on the current market penetration and growth trends.
Prominent participants in our primary research process include:
- Key Opinion Leaders namely the CEOs, CSOs, VPs, purchasing managers, amongst others
- Research and development participants, distributors/suppliers and subject matter experts
Secondary Research includes data extracted from paid data sources:
- Reuters
- Factiva
- Bloomberg
- One Source
- Hoovers
Research Methodology
Key Inclusions
Reach to us
Call us on
+91-74002-42424
Drop us an email at
sales@absolutemarketsinsights.com
Why Absolute Markets Insights?
An effective strategy is the entity that influences a business to stand out of the crowd. An organization with a phenomenal strategy for success dependably has the edge over the rivals in the market. It offers the organizations a head start in planning their strategy. Absolute Market Insights is the new initiation in the industry that will furnish you with the lead your business needs. Absolute Market Insights is the best destination for your business intelligence and analytical solutions; essentially because our qualitative and quantitative sources of information are competent to give one-stop solutions. We inventively combine qualitative and quantitative research in accurate proportions to have the best report, which not only gives the most recent insights but also assists you to grow.